Giant Cell tumors (GCT) are benign tumors with potential for aggressive behavior and
capacity to metastasize. Although rarely lethal, benign bone tumors may be associated with …

The radiologic features of giant cell tumor (GCT) and giant cell reparative granuloma
(GCRG) of bone often strongly suggest the diagnosis and reflect their pathologic …

This WHO classification covers tumors of soft tissue and bone including inherited tumor
syndromes. Each entity is extensively discussed with information on clinicopathological …

Background Many surgeons treat giant cell tumor of bone (GCT) with intralesional curettage.
Wide resection is reserved for extensive bone destruction where joint preservation is …

We provide an overview of imaging, histopathology, genetics, and multidisciplinary
treatment of giant cell tumor of bone (GCTB), an intermediate, locally aggressive but rarely …

Background: Primary and recurrent giant cell tumor of bone is typically benign; however,
rarely giant cell tumor of bone can undergo malignant transformation. Malignancy in giant …

Background Two hundred and fourteen patients with benign giant cell tumor of bone
(GCTB), treated from 1980 to 2007 at the Department of Orthopedics of the University of …

Background: Recent clinical studies have suggested that denosumab is associated with
tumor response and reduced surgical morbidity in patients with giant-cell tumor of bone …

Giant cell tumor is still one of the most controversial and discussed bone tumors. Surgical
treatment options include intralesional excision or segmental resection. Curettage has a …

The nine-year experience with sixty patients who had had a giant-cell tumor of a long bone
was reviewed to determine the rate of recurrence after treatment with curettage and packing …